Expert Interview
Evaluation of Eli Lillys' Obesity Pipeline including Eloralintide and Retatrutide for Chronic Obesity
Ticker(s): LLYInstitution: University of Chicago Medicine
- Associate Professor of Medicine for Division of Endocrinology, Diabetes & Metabolism at the University of Chicago
- Manages 12 patients monthly and has practiced for patients with weight management for the last 14 years
- Research focus is on investigating causes and treatments for obesity and associated metabolic dysfunction and Studying how chronic partial sleep loss, poor sleep quality, and sleep patterns relate to obesity, insulin resistance, inflammation, diabetes, and quality of life.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
